Cart
sales@molnova.com
CCT077791
CAS No. 748777-47-1
CCT077791( —— )
Catalog No. M34060 CAS No. 748777-47-1
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCT077791
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain | Histone Acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number748777-47-1
-
Formula Weight256.67
-
Molecular FormulaC9H5ClN2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(SC(Cl)=C1)C2=CC=C(N(=O)=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
UNC926 hydrochloride
UNC926 hydrochloride is a?methyl-lysine (Kme) reader domain?inhibitor.
-
PBRM1-BD2-IN-3
PBRM1-BD2-IN-3 (compound 12) is a potent PBRM1-BD2 inhibitor with an IC50 of 1.1 μM, used in anticancer research.
-
BY27
BY27, a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anticancer activity, inhibits BD1/BD2 of BRD2, BRD3, BRD4, and BRDT, and suppresses tumor growth.
